default image
Enhanced pretreatment of tail water in refractory pharmaceutical parks and its co-treatment technology with domestic sewage
Refractory pharmaceutical tail water has been intensively pretreated and co-treated to stabilize Level A emissions.
Type
Process technology
Tags
Water pollution control
Wastewater
Tail water
NULL
Applicable industry
Water conservancy, environment and public facilities management
Applications
Wastewater treatment
Key innovations
The innovation of this technology lies in the enhanced pretreatment of ozone oxidation and hydrolytic acidification, combined with co-treatment of domestic sewage, and the use of biological co-metabolism to efficiently and stably solve the problem of standard discharge of refractory pharmaceutical tail water. It has low cost and can be promoted.
Potential economic benefits
This technology enables the co-treatment of refractory pharmaceutical tail water and domestic sewage, and the comprehensive treatment cost per ton of water is about 1.15 yuan. Stable emission standards avoid huge environmental fines and ensure enterprise production.
Potential climate benefits
This technology significantly reduces methane (high GWP gas) emissions produced by anaerobic decomposition in water by efficiently degrading refractory organic matters. Pretreatment improves the biodegradability of wastewater and optimizes the energy efficiency of subsequent A2O co-treatment, which may reduce overall operating energy consumption and potential emissions of nitrogen oxides (such as N2O).
Solution supplier
View more
China Academy of Environmental Sciences
China Academy of Environmental Sciences
China Academy of Environmental Sciences is a national-level environmental research institution committed to solving major national environmental problems and providing scientific and technological support for ecological and environmental decision-making.
Solution details

This technical achievement solves the problem of stable discharge of tail water in refractory pharmaceutical parks, including enhanced pretreatment technologies for ozone oxidation and hydrolytic acidification of tail water in the park, and co-treatment technology for pretreated tail water and domestic sewage. The COD of biologically treated wastewater in the pharmaceutical park reaches the 300mg/L standard. However, it still contains a large amount of refractory organic substances such as p-methyl phenol, dimethyl phthalate, acetophenone, etc., with BOD/COD<0.1. Poor biodegradability. After comparison of process technologies, ozone oxidation, hydrolytic acidification and their combination processes were selected to carry out enhanced pretreatment of the tail water of the pharmaceutical park. After a small scale and a pilot test of 10 tons/day, the key parameters were obtained as follows: ozone dosing of 20~30 mg/L, hydrolytic acidification time of 6~9 hours, BOD/COD can be increased to above 0.3; The pretreated pharmaceutical wastewater and domestic sewage with a COD of 500mg/L are co-treated through the A2O process, and the proportion of pharmaceutical wastewater is controlled to be 20%~30%. Using the principle of biological co-metabolism, the effluent can stably reach the first-class urban sewage A emission standard. The above process technologies have been applied and demonstrated in the construction project of Shenyang Western Sewage Treatment Plant in the middle reaches of Hun River. The scale is 70,000 tons/day of tail water in the pharmaceutical park and 180,000 tons/day of domestic sewage. The comprehensive treatment cost per ton of water is about 1.15 yuan. The treatment of tail water in the industrial park provides a replicable technology and model, with significant environmental, economic and social benefits.

Last updated
00:36:57, Nov 08, 2025
Information contributed by

See original page on

Report